Financial Performance - The company's revenue for Q1 2024 was ¥129,385,035.56, representing a 26.83% increase compared to ¥102,012,228.80 in the same period last year[5] - Net profit attributable to shareholders was ¥14,022,784.51, up 46.99% from ¥9,540,054.26 year-on-year[5] - The total profit for Q1 2024 was ¥16,328,947.58, a 54.68% increase from ¥10,556,882.14 in the same quarter last year[8] - Operating profit for Q1 2024 was ¥16,574,602.57, up 54.0% from ¥10,728,019.80 in the same period last year[19] - Net profit attributable to the parent company was ¥14,022,784.51, representing a 46.5% increase from ¥9,540,054.26 in Q1 2023[19] - Basic and diluted earnings per share increased by 46.94% to ¥0.1753 from ¥0.1193 in the previous year[5] - Basic and diluted earnings per share for Q1 2024 were both ¥0.1753, compared to ¥0.1193 in Q1 2023, reflecting a 47.0% increase[19] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 84.55%, amounting to ¥2,996,038.33 compared to ¥19,397,759.48 in Q1 2023[5] - The net increase in cash and cash equivalents was ¥2,603,936.67, down 93.30% from ¥38,863,475.04 in Q1 2023[9] - Cash flow from operating activities generated a net amount of ¥2,996,038.33, a significant decrease of 84.6% from ¥19,397,759.48 in Q1 2023[21] - The company reported a cash and cash equivalents balance of ¥384,126,213.91 at the end of Q1 2024, up from ¥366,696,430.78 at the end of Q1 2023[22] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥829,064,327.70, a 2.29% increase from ¥810,539,193.07 at the end of the previous year[5] - The company's total assets as of March 31, 2024, amount to 829,064,327.70 RMB, an increase from 810,539,193.07 RMB at the beginning of the period[13] - The total current assets are reported at 711,340,652.66 RMB, compared to 688,933,886.82 RMB at the beginning of the period, reflecting a growth of approximately 3.4%[13] - The total liabilities amount to 126,474,761.12 RMB, up from 122,614,406.68 RMB, indicating an increase of about 3.0%[15] - Total liabilities and equity amounted to ¥829,064,327.70, reflecting a 2.3% increase from ¥810,539,193.07 in the previous year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,094[10] - The largest shareholder, Longkou Sunshine Chemical Co., Ltd., holds 42.83% of shares, totaling 34,260,000 shares[10] Research and Development - Research and development expenses rose by 34.30% to ¥5,669,841.74, reflecting the company's increased investment in R&D[8] - Research and development expenses rose to ¥5,669,841.74, up 34.4% from ¥4,221,623.72 in the previous year[17] Sales and Marketing - The company's sales expenses surged by 162.04% to ¥1,267,953.72, primarily due to increased sales revenue[8] Inventory and Receivables - The accounts receivable increased to 95,507,135.61 RMB from 76,222,556.03 RMB, showing a growth of approximately 25.3%[13] - The inventory level rose to 111,895,059.82 RMB, compared to 102,511,467.92 RMB, marking an increase of about 9.3%[13] Other Information - The company received government subsidies amounting to ¥1,029,992.92, which was a 51.42% decrease compared to the previous year[8] - The company has no preferred shareholders or any changes in restricted shares during the reporting period[12] - The company did not report any new product launches or significant market expansion strategies during this quarter[23]
联合化学(301209) - 2024 Q1 - 季度财报